Ontology highlight
ABSTRACT:
ORGANISM(S): Homo sapiens
SUBMITTER: Keith Ching
PROVIDER: E-GEOD-34211 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
Molecular cancer therapeutics 20120105 3
PF-03814735 is a novel, reversible inhibitor of Aurora kinases A and B that finished a phase I clinical trial for the treatment of advanced solid tumors. To find predictive biomarkers of drug sensitivity, we screened a diverse panel of 87 cancer cell lines for growth inhibition upon PF-03814735 treatment. Small cell lung cancer (SCLC) and, to a lesser extent, colon cancer lines were very sensitive to PF-03814735. The status of the Myc gene family and retinoblastoma pathway members significantly ...[more]